231: Big deal, little deal, or no deal? A 2024 health policy retrospective
Drugs, docs, and mandatory payment models. In this episode, host Abby Burns invites Advisory Board experts Gina Lohr, Sarah Roller, and Paul Trigonoplos to unpack three major health policy topics of 2024. The experts explore how these policies are affecting the industry, how the elections outcomes may impact them, and, critically, how much attention leaders need to pay them going forward.
Audio is streamed directly from the publisher (aphid.fireside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Last week on Radio Advisory, we broke down what healthcare leaders need to know for 2025 and beyond following the recent elections. But before we move on from 2024 completely, we have to acknowledge that there’s been a lot moving in the policy space this year, and frankly, there have probably been a few important policy areas on your radar that we haven’t discussed.
That’s why this week, host Abby Burns invites Advisory Board experts Gina Lohr, Sarah Roller, and Paul Trigonoplos to dive into three major policy areas of the last year: Medicare drug negotiations, changes to physician employment and payment, and an emerging mandatory bundled payment model called TEAM. The experts unpack how these policies are affecting the industry, how the elections outcomes may impact them, and, critically, how much attention leaders should be paying them going forward. In other words, should leaders consider each policy a big deal, a little deal, or no deal?
Links:
- Ep. 230: Elections results are in: What healthcare leaders need to know
- State-level healthcare ballot measures that passed (and failed)
- CMS’ TEAM payment model is here. How should hospitals prepare?
- Transforming Episode Accountability Model (TEAM)
- Your guide to CMS' 14 value-based payment models
- Medicare announces 10 new drug prices following negotiations
- A federal judge just blocked FTC's noncompete ban
- The Hospital Benchmark Generator
- Market Scenario Planner
(Correction: An earlier version of this episode misstated that there is a $200 out-of-pocket cap on drug spending going into place. That number is $2,000 and references the Medicare Part D out-of-pocket cap set to begin in 2025. We have removed the number from the audio.)
Get exclusive, early access to Advisory Board’s annual “What CEOs need to know” briefing.
2 ways labs can embrace innovation to drive revenue and accelerate growth
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.